<VariationArchive VariationID="559782" VariationName="NM_000046.5(ARSB):c.427del (p.Val143fs)" VariationType="Deletion" Accession="VCV000559782" Version="13" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-17" DateCreated="2018-08-24" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="550497" VariationID="559782">
      <GeneList>
        <Gene Symbol="ARSB" FullName="arylsulfatase B" GeneID="411" HGNC_ID="HGNC:714" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78777209" stop="78985958" display_start="78777209" display_stop="78985958" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="78073031" stop="78282356" display_start="78073031" display_stop="78282356" Strand="-" />
          </Location>
          <OMIM>611542</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000046.5(ARSB):c.427del (p.Val143fs)</Name>
      <CanonicalSPDI>NC_000005.10:78969077:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78969078" stop="78969078" display_start="78969078" display_stop="78969078" variantLength="1" positionVCF="78969077" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="78264901" stop="78264901" display_start="78264901" display_stop="78264901" variantLength="1" positionVCF="78264900" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V143fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.78969079del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.78969079del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.78264902del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.78264902del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007089.1" sequenceAccession="NG_007089" sequenceVersion="1" change="g.22457del">
            <Expression>NG_007089.1:g.22457del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000046.5" sequenceAccession="NM_000046" sequenceVersion="5" change="c.427del" MANESelect="true">
            <Expression>NM_000046.5:c.427del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000037.2" sequenceAccession="NP_000037" sequenceVersion="2" change="p.Val143fs">
            <Expression>NP_000037.2:p.Val143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198709.3" sequenceAccession="NM_198709" sequenceVersion="3" change="c.427del">
            <Expression>NM_198709.3:c.427del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_942002.1" sequenceAccession="NP_942002" sequenceVersion="1" change="p.Val143fs">
            <Expression>NP_942002.1:p.Val143fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000046.5" sequenceAccession="NM_000046" sequenceVersion="5" change="c.427delG" MANESelect="true">
            <Expression>NM_000046.5:c.427delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="766914147" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000046.5(ARSB):c.427del (p.Val143fs) AND Mucopolysaccharidosis type 6" Accession="RCV000677561" Version="11">
        <ClassifiedConditionList TraitSetID="233">
          <ClassifiedCondition DB="MedGen" ID="C0026709">Mucopolysaccharidosis type 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-16" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000046.5(ARSB):c.427del (p.Val143fs) AND Metachromatic leukodystrophy" Accession="RCV000779748" Version="1">
        <ClassifiedConditionList TraitSetID="787">
          <ClassifiedCondition DB="MedGen" ID="C0023522">Metachromatic leukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-16" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2018-08-24" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14974081</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16435196</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17458871</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17643332</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18406185</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22133300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24767253</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="787" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5508" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Metachromatic leukodystrophy</ElementValue>
                <XRef ID="Metachromatic+leukodystrophy/4691" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018868" DB="MONDO" />
                <XRef ID="396338004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukoencephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfatide lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral sclerosis diffuse metachromatic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroside sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arylsulfatase A Deficiency</ElementValue>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MLD</ElementValue>
                <XRef Type="MIM" ID="250100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Arylsulfatase A deficiency (also known as metachromatic leukodystrophy or MLD) is characterized by three clinical subtypes: late-infantile MLD, juvenile MLD, and adult MLD. Age of onset within a family is usually similar. The disease course may be from several years in the late-infantile-onset form to decades in the juvenile- and adult-onset forms. Late-infantile MLD. Onset is before age 30 months. Typical presenting findings include weakness, hypotonia, clumsiness, frequent falls, toe walking, and dysarthria. As the disease progresses, language, cognitive, and gross and fine motor skills regress. Later signs include spasticity, pain, seizures, and compromised vision and hearing. In the final stages, children have tonic spasms, decerebrate posturing, and general unawareness of their surroundings. Juvenile MLD. Onset is between age 30 months and 16 years. Initial manifestations include decline in school performance and emergence of behavioral problems, followed by gait disturbances. Progression is similar to but slower than in the late-infantile form. Adult MLD. Onset occurs after age 16 years, sometimes not until the fourth or fifth decade. Initial signs can include problems in school or job performance, personality changes, emotional lability, or psychosis; in others, neurologic symptoms (weakness and loss of coordination progressing to spasticity and incontinence) or seizures initially predominate. Peripheral neuropathy is common. Disease course is variable – with periods of stability interspersed with periods of decline – and may extend over two to three decades. The final stage is similar to earlier-onset forms.</Attribute>
                <XRef ID="NBK1130" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3230" />
                <XRef ID="3230" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301309</ID>
                <ID Source="BookShelf">NBK1130</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="512" DB="Orphanet" />
              <XRef ID="C0023522" DB="MedGen" />
              <XRef ID="MONDO:0018868" DB="MONDO" />
              <XRef Type="MIM" ID="250100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="233" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3041" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type VI</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+VI/4921" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis type 6</ElementValue>
                <XRef ID="MONDO:0009661" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 6</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arylsulfatase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylgalactosamine-4-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maroteaux Lamy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS VI</ElementValue>
                <XRef Type="MIM" ID="253200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS6</ElementValue>
                <XRef Type="MIM" ID="253200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7095" />
                <XRef ID="7095" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="Wood et al., 2012">
                <ID Source="PubMed">22405600</ID>
              </Citation>
              <XRef ID="583" DB="Orphanet" />
              <XRef ID="C0026709" DB="MedGen" />
              <XRef ID="MONDO:0009661" DB="MONDO" />
              <XRef Type="MIM" ID="253200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1567063" SubmissionDate="2018-04-17" DateLastUpdated="2018-08-24" DateCreated="2018-08-24">
        <ClinVarSubmissionID localKey="NM_000046.4:c.427del|OMIM:253200" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000803074" DateUpdated="2018-08-24" DateCreated="2018-08-24" Type="SCV" Version="1" SubmitterName="Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova" OrgID="506414" OrganizationCategory="laboratory" OrgAbbreviation="LAB-DTLD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16435196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14974081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17458871</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24767253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17643332</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18406185</ID>
          </Citation>
          <Comment Type="public">Frameshift variant(PVS1); In vitro functional studies supportive of a damaging effect on the gene product (demonstrated nonsense mediated RNA decay; PS3); Very low frequency in ExAc (PM2)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="12" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000046.4:c.427del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253200" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">30118150</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB3915908</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1793140" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000046.3:c.427delG|MedGen:C0023522" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000916523" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16435196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17458871</ID>
          </Citation>
          <Comment>Variant summary: The ARSB c.427delG (p.Val143SerfsX41) variant results in a premature termination codon, predicted to cause a truncated or absent ARSB protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant was found in 6/277178 control chromosomes at a frequency of 0.0000216, which does not exceed the estimated maximal expected allele frequency of a pathogenic ARSB variant (0.0022361). The variant has been reported in numerous affected individuals in the literature. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000046.3:c.427delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Metachromatic leukodystrophy</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0023522" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2872904" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000046.5:c.427delG|Mucopolysaccharidosis type VI" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001457629" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000046.5:c.427delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Mucopolysaccharidosis type VI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3105543" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4855662|MedGen:C0026709" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579935" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17458871</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22133300</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14974081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16435196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17643332</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val143Serfs*41) in the ARSB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). This variant is present in population databases (rs766914147, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with mucopolysaccharidosis type VI (PMID: 14974081, 16435196, 17643332). ClinVar contains an entry for this variant (Variation ID: 559782). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.78264901del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0026709" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932506" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000005.10:g.78969078_78969078delC|OMIM:253200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518524" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARSB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.10:g.78969078_78969078delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7853147" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000046.5:c.427del|OMIM:253200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004209280" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000046.5:c.427del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1567063" TraitType="Disease" MappingType="XRef" MappingValue="253200" MappingRef="OMIM">
        <MedGen CUI="C0026709" Name="Mucopolysaccharidosis type 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1793140" TraitType="Disease" MappingType="Name" MappingValue="Metachromatic leukodystrophy" MappingRef="Preferred">
        <MedGen CUI="C0023522" Name="Metachromatic leukodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4932506" TraitType="Disease" MappingType="XRef" MappingValue="253200" MappingRef="OMIM">
        <MedGen CUI="C0026709" Name="Mucopolysaccharidosis type 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7853147" TraitType="Disease" MappingType="XRef" MappingValue="253200" MappingRef="OMIM">
        <MedGen CUI="C0026709" Name="Mucopolysaccharidosis type 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3105543" TraitType="Disease" MappingType="XRef" MappingValue="C0026709" MappingRef="MedGen">
        <MedGen CUI="C0026709" Name="Mucopolysaccharidosis type 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2872904" TraitType="Disease" MappingType="Name" MappingValue="Mucopolysaccharidosis type VI" MappingRef="Preferred">
        <MedGen CUI="C0026709" Name="Mucopolysaccharidosis type 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

